Status:
COMPLETED
Study to Assess Platelet Dysfunction With Verify Now Assay
Lead Sponsor:
NYU Langone Health
Conditions:
Platelet Aggregation Defects
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloprolife...
Detailed Description
Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The verify now assay is designed to assess platelet function based on the ability of activated platelets to bind ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- \- Patients with common blood disorders such as immune thrombocytopenia purpura(ITP) myelodysplastic syndrome MDS)and myeloproliferative disorders (MPV)
- Exclusion Criteria
- \- Patients with normal platelet counts
Exclusion
Key Trial Info
Start Date :
December 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT01167218
Start Date
December 1 2009
End Date
February 1 2012
Last Update
February 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Winthrop University Hospital Oncology/Hematology Division
Mineola, New York, United States, 11501